Why Moderna Stock Lost 30% Last Month?
- Thursday, August 20, 2020, 7:14
- Market
- Add a comment
Moderna (NASDAQ:MRNA), a front runner in the race for a Covid-19 vaccine, has seen its stock drop by about 30% over the last month, falling from close to $95 per share on July 17 to about $67 currently. So what’s driving the sell-off? We think it comes down to two factors…
About the Author
admin123 has written 23527 stories on this site.
